_the-imsavar-project-making-immunomodulatory-therapies-safer-preview-1.jpg "The imSAVAR project: making immunomodulatory therapies safer from immunomodulatory therapy Video Screenshot Preview 1")
Gallery_the-imsavar-project-making-immunomodulatory-therapies-safer-preview-3.jpg "The imSAVAR project: making immunomodulatory therapies safer from immunomodulatory therapy Video Screenshot Preview 3")
Gallery_the-imsavar-project-making-immunomodulatory-therapies-safer-preview-hqdefault.jpg "The imSAVAR project: making immunomodulatory therapies safer from immunomodulatory therapy Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 26 seconds
👁 View: 112 times
Play Audio:👁 View: 112 times
Description:
VJHemOnc – Video Journal of Hematology u0026 HemOnc
VJHemOnc – Video Journal of Hematology u0026 HemOnc
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_proven-benefits-of-probiotics-during-pregnancy-and-breastfeeding.webp "Can Probiotics Really Treat Lactational Mastitis? nLactational mastitis is an infection of one or more lobules of the mammary gland, occurring up to 33% of lactating mothers. Although the condition may happen at any point during the lactation period, between 75-95% of cases occur within the first 12 weeks, with the frequency particularly higher during the second and third weeks postpartum. nnNew research shows that lactational mastitis is a dysbiotic process. Significant levels of beneficial mic")
_immunomodulatory-drugs.webp "Myeloma UK")
_treating-ibd-immunomodulators.webp "Crohn's u0026 Colitis Foundation")
_ido1-indoleamine-23-dioxygenase.webp "IDO1 is an immunosuppressive enzyme that leads to regulatory T-cell generation and activation, and allows tumors to escape from immune surveillance.nnInhibition of immunomodulatory mechanisms with IDO1 inhibitor-based combination therapy may re-establish anti-tumor immunity.")
_immunomodulators-part-2-immunostimulants.webp "Professor Dave Explains")
_what-should-you-know-about-myeloma-treatment-options.webp "Dr. Peter Forsberg outlines options in the myeloma treatment toolkit, including targeted therapies, chemotherapy, immunotherapy, and combination approaches —and explains how the recovery process from stem cell transplant has improved.nnDr. Peter Forsberg is assistant professor of medicine at the University of Colorado School of Medicine and is a specialist in multiple myeloma. More about Dr. Forsberg here: https://www.cudoctors.com/Find_A_Doctor/Profile/24672.")
_pharmacology-immune-system-drugs-full-video-nursing-rn-pn-nclex.webp "Simple Nursing")
_pharmacology-immunosuppressants-made-easy.webp "Speed Pharmacology")
_proven-benefits-of-probiotics-during-pregnancy-and-breastfeeding.jpg)
_immunomodulatory-drugs.jpg)
_treating-ibd-immunomodulators.jpg)
_ido1-indoleamine-23-dioxygenase.jpg)
_immunomodulators-part-2-immunostimulants.jpg)
_what-should-you-know-about-myeloma-treatment-options.jpg)
_pharmacology-immune-system-drugs-full-video-nursing-rn-pn-nclex.jpg)
_pharmacology-immunosuppressants-made-easy.jpg)
![[+]](/images/menu.gif){kind=small}